Exploring how Hsp70 interacts with DNA damage response mechanisms
Understanding the reciprocal regulation between Hsp70 and the DNA damage response
This study is looking at how a protein called Hsp70 helps cells fix damaged DNA, which is important for keeping our cells healthy and preventing diseases like cancer, and it could lead to new treatments for people facing these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Carolina Charlotte NIH-funded |
| Lab location | 1 site (Charlotte, United States) |
| Project ID | NIH-10747331 on NIH RePORTER |
What this research studies
This research investigates the relationship between Hsp70, a molecular chaperone, and the DNA damage response (DDR) in cells. It focuses on how Hsp70 helps stabilize proteins involved in repairing DNA and how its function can be altered through specific phosphorylation. By understanding these interactions, the research aims to uncover new insights into how cells maintain DNA integrity, which is crucial for preventing cell death and cancer. Patients may benefit from this research as it could lead to new therapeutic strategies for conditions related to DNA damage, including cancers and neurodegenerative diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of cancer or neurodegenerative diseases, particularly those related to DNA damage.
Not a fit: Patients with conditions unrelated to DNA damage or those who do not have a genetic predisposition to cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve DNA repair mechanisms, potentially reducing the risk of cancer and neurodegenerative diseases.
How similar studies have performed: Previous research has shown promising results in understanding the role of molecular chaperones in DNA repair, indicating that this approach has potential for success.
Where this research is happening
Charlotte, United States
- University of North Carolina Charlotte — Charlotte, United States (Active)
Researchers
- Principal investigator: Truman, Andrew William — University of North Carolina Charlotte
- Study coordinator: Truman, Andrew William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.